Stay updated on Daratumumab in Bortezomib Combo for Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page.

Latest updates to the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status is updated to no longer looking for participants and the record version is updated to v3.6.0, replacing the previous 3.5.5 version. This indicates enrollment completion and a new official revision of the study record.SummaryDifference0.2%

- Check8 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, indicating a newer site version is in use. The change is a system-level update and does not modify the study data or visible content of the record.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe site footer now shows Revision: v3.5.4, indicating a minor version update. This replaces the previous Revision: v3.5.3 as part of routine maintenance.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s visible revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release update rather than any modification to the clinical trial’s record history.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.0%

Stay in the know with updates to Daratumumab in Bortezomib Combo for Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page.